Dr Reddy’s Laboratories

Dr Reddy's to sell US, Canada territory rights for migraine drug to BDSI

Dr Reddy's to sell US, Canada territory rights for migraine drug to BDSI

Drug firm Dr Reddy's Laboratories on Wednesday said it has entered into a definitive agreement with BioDelivery Sciences International, I...Read More

Indian pharma industry to touch $130 bn by 2030: Dr Reddy's

Indian pharma industry to touch $130 bn by 2030: Dr Reddy's

The Indian pharmaceutical industry is expected to grow almost by three times to about $130 billion dollars by 2030, Chairman of Dr Reddy'...Read More

India's drug regulator refuses to grant emergency-use authorisation to Covid vaccine Sputnik-Light

India's drug regulator refuses to grant emergency-use authorisation to Covid vaccine Sputnik-Light

New DelhiIndia's drug regulator has refused to grant emergency-use authorisation to single-dose Covid-19 vaccine Sputnik-Light, while rul...Read More

Dr Reddy's Laboratories announces commercial launch of 2-DG used in treatment of COVID-19

Dr Reddy's Laboratories announces commercial launch of 2-DG used in treatment of COVID-19

Hyderabad (Telangana): Dr. Reddy's Laboratories Limited on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG), an anti-CO...Read More

Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

Dr Reddy's Laboratories on Tuesday announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult pat...Read More

Dr Reddy’s Laboratories' subsidiary exploring legal options after asked to pay $46.25 mn to Hatchtech

Dr Reddy’s Laboratories' subsidiary exploring legal options after asked to pay $46.25 mn to Hatchtech

The International Center for Dispute Resolution, US has asked Promius Pharma, a subsidiary of Dr. Reddy’s Laboratories Limited to pay $46...Read More

Stocks to Watch: InterGlobe Aviation, Emami, Bank of Maharashtra, Dr Reddy's Laboratories, Havells India among others

Stocks to Watch: InterGlobe Aviation, Emami, Bank of Maharashtra, Dr Reddy's Laboratories, Havells India among others

Here is a list of stocks that one should keep a watch on, when the markets open on Monday. InterGlobe Aviation: The parent company of the...Read More

Mumbai: BMC disqualifies nine COVID-19 vaccine supply bids; will now procure Sputnik V doses from Dr Reddy's

Mumbai: BMC disqualifies nine COVID-19 vaccine supply bids; will now procure Sputnik V doses from Dr Reddy's

MUMBAI: In a major development, the BMC on Friday disqualified all the nine bidders who had responded to the civic body's global tender f...Read More

Shilpa Medicare ties up with Dr Reddy's to manufacture Sputnik V vaccine; share price up

Shilpa Medicare ties up with Dr Reddy's to manufacture Sputnik V vaccine; share price up

Drug firm Shilpa Medicare on Monday said its arm has entered into a definitive agreement with Dr Reddy's Laboratories for manufacturing o...Read More

Second batch of 60,000 Sputnik V vaccine reaches Hyderabad

Second batch of 60,000 Sputnik V vaccine reaches Hyderabad

HyderabadAs many as 60,000 doses of the second batch of Russia’s Covid-19 vaccine Sputnik V on Sunday landed at Rajiv Gandhi Internationa...Read More

Dr Reddy's Laboratories launch antibiotic medication in US market

Dr Reddy's Laboratories launch antibiotic medication in US market

Dr Reddy's Laboratories on Wednesday said it has launched Ertapenem for Injection, an antibiotic medication, in the US market.The newly l...Read More

FPJ Explains: How much will coronavirus vaccine cost in India?

FPJ Explains: How much will coronavirus vaccine cost in India?

As we anticipate eagerly the arrival of a COVID-19 vaccine, here are the details on how much different vaccines could cost for the publi...Read More

Dr Reddy's isolates data centre services after detecting cyber-attack

Dr Reddy's isolates data centre services after detecting cyber-attack

Hyderabad-based drugmaker Dr Reddy's Laboratories Thursday said that it has isolated all data centre services following a cyber-attack.In...Read More

Dr Reddy’s faces class action suit in US court

Dr Reddy’s faces class action suit in US court

Hyderabad: Dr Reddy’s Laboratories (DRL) has said a law firm representing a purported investor has filed a class action suit in a USA cou...Read More

Dr Reddy’s Lab acquires Kolkata-based NBFC

Dr Reddy’s Lab acquires Kolkata-based NBFC

New Delhi: Dr Reddy’s Laboratories announced that it has acquired 100 per cent stake in Imperial Credit Private Ltd, a Kolkata-based non-...Read More

DRL gets adverse ruling in US over patent infringement case

DRL gets adverse ruling in US over patent infringement case

New Delhi, Drug major Dr Reddy’s Laboratories today said it has received an unfavourable ruling in a US court regarding a patent infringe...Read More

Driven by anti-diabetic & cardiac drug sales, Indian pharma grew by 7.2%

Driven by anti-diabetic & cardiac drug sales, Indian pharma grew by 7.2%

New Delhi: Sales in the Indian pharmaceutical market grew 7.2 per cent on year to Rs 91.31 billion in December on account of strong growt...Read More

placeholder

Good show by emerging market companies : Boston Consulting Group

Mumbai  : Despite a slowdown in the global economy, the CAGR of emerging market companies stood at 13 per cent, comparaed to those in mat...Read More

Dr Reddy’s signs US licensing agreement with XenoPort

Dr Reddy’s signs US licensing agreement with XenoPort

New Delhi: Drug major Dr Reddy’s Laboratories has entered into a US licensing pact with XenoPort for the development and commercialisatio...Read More

placeholder

Dr Reddy’s Lab Q2 net rises 26% to Rs 722 cr

Hyderabad : Aided by good sales growth coupled with new product launches, drug major Dr Reddy’s Laboratories reported a 25.74 % jump in c...Read More

Free Press Journal

www.freepressjournal.in